Gsk (GLAXF) Intangibles (2009 - 2026)

Gsk's Intangibles history runs 18 years deep, the most recent figure standing at $24.5 billion for Q1 2026.

• In Q1 2026, Intangibles rose 19.42% year-over-year to $24.5 billion; the TTM figure through Mar 2026 stood at $24.5 billion (up 19.42% YoY), while the FY2025 annual figure was $22.1 billion, up 11.34% from the prior year.
• Intangibles was $24.5 billion for Q1 2026 at Gsk, up from $22.3 billion in the prior quarter.
• In the past five years, Intangibles ranged from a high of $26.0 billion in Q1 2022 to a low of $14.3 billion in Q2 2022.
• Historically, Intangibles has averaged $20.0 billion across 5 years, with a median of $19.5 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Intangibles slumped 65.07% in 2022, then jumped 35.72% in 2023.
• A 5-year view of Intangibles shows it stood at $16.8 billion in 2022, then gained by 9.14% to $18.3 billion in 2023, then increased by 8.64% to $19.9 billion in 2024, then increased by 11.87% to $22.3 billion in 2025, then increased by 9.77% to $24.5 billion in 2026.
• The last three Intangibles figures came in at $24.5 billion (Q1 2026), $22.3 billion (Q4 2025), and $22.8 billion (Q3 2025), per Business Quant data.